What gluteal tendinopathy is and why it often stalls

Months of hip pain that radiates to the outer thigh or buttock, made worse by stairs, prolonged sitting, or rolling over in bed — and yet nothing seems to shift it. For many people, the missing explanation is gluteal tendinopathy (GT): a condition in which the gluteus medius or gluteus minimus tendons, where they attach to the bony prominence of the greater trochanter, lose their capacity to handle everyday load.

GT is not hip joint disease, and it is not bursitis, though it is still frequently labelled as 'trochanteric bursitis' in GP consultations. The underlying problem is degenerative overload — tendons that have been asked to do more than their current capacity allows. It is most common in perimenopausal women, though it occurs across ages and activity levels.

What makes GT self-perpetuating is a matter of geometry. Positions that compress the tendon against the greater trochanter — crossing the legs, walking with a wide hip-swing, or sleeping on the affected side — reload an already sensitised structure. Rest removes useful stimulus without restoring capacity; generic hip stretches can actually worsen compressive load. Without a structured approach to rebuilding tendon tolerance, the condition tends to stall rather than resolve.

What gold-standard self-management actually involves

The phrase 'self-management' carries very different meanings depending on the clinical context. In the GT evidence base, it refers to a specific structured approach called Education and Exercise (EDX): a supervised, progressive programme combining education about compressive load with graded tendon-loading exercise — typically delivered across 8 to 12 weeks with a physiotherapist who specialises in tendinopathy.

The anchor trial is the Australian LEAP study, which compared 14 sessions of EDX over eight weeks against corticosteroid injection and a 'wait and see' approach. EDX produced significantly greater improvement in pain and global rating of change at both eight and 52 weeks. This is the benchmark against which other treatments are now measured.

The education component teaches patients to identify and reduce compressive positions — how they sit, stand, and sleep — while the exercise component rebuilds the tendon's capacity to handle load through carefully graduated movements. A 2025 feasibility study of heavy slow resistance (HSR) training combined with education found that participants (mean age 52, 79% female) achieved 100% session adherence across 12 weeks, with significant improvements in pain, validated scores, and hip muscle strength — suggesting HSR may be an effective variant of the progressive loading model.

Many patients reach a specialist having tried rest, over-the-counter pain relief, or general hip stretches. Those approaches do not meet the threshold of structured self-management. Completing a properly supervised EDX or equivalent programme is the genuine starting point — not an optional first step.

Signs that structured self-management has reached its limit

Knowing when to stop waiting is often the hardest part. The clearest, evidence-based threshold is straightforward: if symptoms have not meaningfully improved — or have continued to worsen — after completing a genuine 8 to 12 week structured EDX programme with a tendinopathy-skilled physiotherapist, escalation to specialist assessment is warranted. A 2025 systematic review of randomised controlled trials confirms that exercise and education produces only small effects in the medium and long term for a meaningful proportion of patients, making clear that self-management has a ceiling.

Functional signals — rather than how long symptoms have been present — are the most reliable guide. The following warrant specialist referral:

• Persistent pain when lying on the affected side, regularly disrupting sleep
• A progressive or worsening limp
• Significant difficulty rising from a chair or sitting down
• Noticeably reduced walking tolerance compared with baseline
• Difficulty lifting the leg sideways, or hip weakness that is not improving despite consistent loading

Duration of symptoms on its own is not the deciding factor. Someone with three months of worsening function who has completed a structured programme is in a different position from someone who has had intermittent ache for two years without trying supervised exercise. It is the combination of symptom burden, functional loss, and non-response to structured care that together indicate a specialist is needed.

A brief note on why some patients plateau: imaging sub-studies suggest structural complexity — including tendon tears and bilateral involvement — is common at this stage, a point worth exploring before choosing the next step.

Why scans alone should not determine your next step

Imaging results have an outsized influence on how patients — and sometimes clinicians — decide whether to act. A secondary analysis of 204 participants from the LEAP trial directly challenges the logic of waiting for scan severity to guide that decision: MRI severity of tendon changes was not associated with levels of pain, function, or disability. In other words, a patient with alarming-looking tendon changes on MRI may be functioning well, while someone with relatively modest imaging findings may be severely limited.

Structural findings are also far more common than many patients expect. In that same cohort, 64% had pathology affecting both the gluteus medius and gluteus minimus tendons, 42% had at least one tendon tear (the majority partial-thickness), and 36% had calcifications. These findings were present across participants who responded to conservative care — they are not markers of inevitable surgical need.

Two practical points follow from this. A scan that looks unremarkable does not rule out clinically significant GT. And a scan that looks severe does not mean surgery is the next step. Specialist assessment draws on the full clinical picture — sleep disruption, walking tolerance, functional strength — with imaging as one interpretive tool among several, not a binary verdict. Escalation decisions should rest on symptom burden and non-response to structured care, not on what a scan does or does not show.

What specialist-level care looks like in practice

Specialist care for GT follows a sequence rather than a menu — each stage is considered only after the one before it has been genuinely exhausted.

At the first tier, a specialist will often review and optimise the physiotherapy programme itself: ensuring load progression is appropriate, addressing biomechanical factors, and reinforcing frontal-plane exercise. A 2025 qualitative study of 20 international GT experts — physiotherapists, physicians, and surgeons — describes specialist appointments as 45-minute sessions structured around individually sequenced interventions, with sleep quality, walking capacity, and sit-to-stand performance used as the principal progress markers throughout.

When optimised physiotherapy has not achieved sufficient improvement, injection or shockwave therapy enters the picture. Corticosteroid injection has moderate evidence for a small short-term reduction in pain (SMD 0.51), but it performs less well at longer follow-up than shockwave, and current guidance does not support it as a standalone first-line treatment. Platelet-rich plasma (PRP) is superior to corticosteroid for short-term function. Focused extracorporeal shockwave therapy (f-ESWT) shows the largest long-term pain effect compared to corticosteroid (SMD 5.77), which is why specialists experienced in GT may favour it when durable relief is the goal. Which modality is appropriate depends on the individual clinical picture; a specialist will weigh these options in the context of the whole patient.

Surgical hip abductor tendon repair — reattaching the torn tendon to the greater trochanter using surgical anchors — is reserved for cases in which physiotherapy, injection, and shockwave have each failed to restore acceptable function.

Delaying specialist involvement carries its own risks. A propensity-matched study of patients undergoing total hip arthroplasty found that those with pre-existing GT had significantly worse postoperative pain, satisfaction, and function than matched controls — a finding that reinforces why unresolved GT warrants timely specialist input, particularly before any other surgical procedures are considered.

How to find the right specialist for gluteal tendinopathy

For most patients who have not yet completed a structured tendinopathy programme, a physiotherapist with specific tendinopathy expertise is the right first specialist — not a surgeon, and not a generic outpatient referral to an exercise class.

If a properly supervised 8 to 12 week programme has not delivered sufficient progress, the next step is a sports medicine physician or MSK doctor. They can assess injection and shockwave options, interpret the full clinical picture across symptom burden and function, and co-ordinate a stepped plan. Surgical assessment becomes relevant only after physiotherapy, injection, and shockwave therapy have each been tried and found insufficient; at that stage, an orthopaedic surgeon with experience in hip soft-tissue repair is the appropriate specialist.

When vetting any specialist at any of these stages, three questions are worth raising: does the clinician offer progressive load-based tendon rehabilitation, or primarily injections alone? Are they familiar with the LEAP trial approach and its evidence base? And if conservative care proves insufficient, can they co-ordinate — or refer into — a staged multidisciplinary plan? A 'yes' to each suggests the clinician is working within the current evidence rather than around it.

Search MSK lists physiotherapists, sports medicine clinicians, and orthopaedic surgeons across the UK who treat gluteal tendinopathy — filter by region and specialty to find a practitioner whose expertise fits your current stage of care.